0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bovine Bone Collagen Peptide Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-39A16940
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Bovine Bone Collagen Peptide Market Research Report 2024
BUY CHAPTERS

Global Bovine Bone Collagen Peptide Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-39A16940
Report
November 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bovine Bone Collagen Peptide Market

The global Bovine Bone Collagen Peptide market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Bovine bone collagen peptide refers to a type of collagen protein derived from the bones of cattle. Collagen is the most abundant protein in mammals and is a key component of connective tissues such as skin, bones, tendons, and ligaments. Bovine bone collagen peptide is produced by breaking down the collagen from bovine bones into smaller peptides through processes like enzymatic hydrolysis.These collagen peptides are often used in dietary supplements, cosmetics, and medical products due to their potential health and skincare benefits. In dietary supplements, bovine bone collagen peptides are believed to support joint health, bone density, and skin elasticity. In cosmetic products, they are commonly included for their moisturizing properties and potential to promote skin firmness and reduce the appearance of wrinkles.
From a downstream perspective, Food accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bovine Bone Collagen Peptide leading manufacturers including SEMNL, Honine Group, LONGBEI, Nutra Food Ingredients, Muyuankangtai, Hebei Hongtao Bioengineering, Shandong Jellice Biotechnology, Gelken Gelatin, Jianke Food Technology, etc., dominate supply; the top five capture approximately % of global revenue, with SEMNL leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bovine Bone Collagen Peptide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Bovine Bone Collagen Peptide Market Report

Report Metric Details
Report Name Bovine Bone Collagen Peptide Market
Segment by Type
  • Protein<90%
  • Protein≥90%
Segment by Application
  • Food
  • Cosmetics
  • Pharmaceutical
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company SEMNL, Honine Group, LONGBEI, Nutra Food Ingredients, Muyuankangtai, Hebei Hongtao Bioengineering, Shandong Jellice Biotechnology, Gelken Gelatin, Jianke Food Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Bovine Bone Collagen Peptide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Bovine Bone Collagen Peptide Market report?

Ans: The main players in the Bovine Bone Collagen Peptide Market are SEMNL, Honine Group, LONGBEI, Nutra Food Ingredients, Muyuankangtai, Hebei Hongtao Bioengineering, Shandong Jellice Biotechnology, Gelken Gelatin, Jianke Food Technology

What are the Application segmentation covered in the Bovine Bone Collagen Peptide Market report?

Ans: The Applications covered in the Bovine Bone Collagen Peptide Market report are Food, Cosmetics, Pharmaceutical

What are the Type segmentation covered in the Bovine Bone Collagen Peptide Market report?

Ans: The Types covered in the Bovine Bone Collagen Peptide Market report are Protein<90%, Protein≥90%

1 Study Coverage
1.1 Introduction to Bovine Bone Collagen Peptide: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bovine Bone Collagen Peptide Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Protein<90%
1.2.3 Protein≥90%
1.3 Market Segmentation by Application
1.3.1 Global Bovine Bone Collagen Peptide Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food
1.3.3 Cosmetics
1.3.4 Pharmaceutical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bovine Bone Collagen Peptide Revenue Estimates and Forecasts 2020-2031
2.2 Global Bovine Bone Collagen Peptide Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bovine Bone Collagen Peptide Sales Estimates and Forecasts 2020-2031
2.4 Global Bovine Bone Collagen Peptide Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Bovine Bone Collagen Peptide Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Bovine Bone Collagen Peptide Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Bovine Bone Collagen Peptide Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Protein<90% Market Size by Manufacturers
4.5.2 Protein≥90% Market Size by Manufacturers
4.6 Global Bovine Bone Collagen Peptide Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Bovine Bone Collagen Peptide Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Bovine Bone Collagen Peptide Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Bovine Bone Collagen Peptide Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Bovine Bone Collagen Peptide Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Bovine Bone Collagen Peptide Sales and Revenue by Type (2020-2031)
7.4 North America Bovine Bone Collagen Peptide Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Bovine Bone Collagen Peptide Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Bovine Bone Collagen Peptide Sales and Revenue by Type (2020-2031)
8.4 Europe Bovine Bone Collagen Peptide Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Bovine Bone Collagen Peptide Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Bovine Bone Collagen Peptide Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Bovine Bone Collagen Peptide Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Bovine Bone Collagen Peptide Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Bovine Bone Collagen Peptide Sales and Revenue by Type (2020-2031)
10.4 Central and South America Bovine Bone Collagen Peptide Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Bovine Bone Collagen Peptide Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Bovine Bone Collagen Peptide Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Bovine Bone Collagen Peptide Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Bovine Bone Collagen Peptide Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 SEMNL
12.1.1 SEMNL Corporation Information
12.1.2 SEMNL Business Overview
12.1.3 SEMNL Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.1.4 SEMNL Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 SEMNL Bovine Bone Collagen Peptide Sales by Product in 2024
12.1.6 SEMNL Bovine Bone Collagen Peptide Sales by Application in 2024
12.1.7 SEMNL Bovine Bone Collagen Peptide Sales by Geographic Area in 2024
12.1.8 SEMNL Bovine Bone Collagen Peptide SWOT Analysis
12.1.9 SEMNL Recent Developments
12.2 Honine Group
12.2.1 Honine Group Corporation Information
12.2.2 Honine Group Business Overview
12.2.3 Honine Group Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.2.4 Honine Group Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Honine Group Bovine Bone Collagen Peptide Sales by Product in 2024
12.2.6 Honine Group Bovine Bone Collagen Peptide Sales by Application in 2024
12.2.7 Honine Group Bovine Bone Collagen Peptide Sales by Geographic Area in 2024
12.2.8 Honine Group Bovine Bone Collagen Peptide SWOT Analysis
12.2.9 Honine Group Recent Developments
12.3 LONGBEI
12.3.1 LONGBEI Corporation Information
12.3.2 LONGBEI Business Overview
12.3.3 LONGBEI Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.3.4 LONGBEI Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 LONGBEI Bovine Bone Collagen Peptide Sales by Product in 2024
12.3.6 LONGBEI Bovine Bone Collagen Peptide Sales by Application in 2024
12.3.7 LONGBEI Bovine Bone Collagen Peptide Sales by Geographic Area in 2024
12.3.8 LONGBEI Bovine Bone Collagen Peptide SWOT Analysis
12.3.9 LONGBEI Recent Developments
12.4 Nutra Food Ingredients
12.4.1 Nutra Food Ingredients Corporation Information
12.4.2 Nutra Food Ingredients Business Overview
12.4.3 Nutra Food Ingredients Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.4.4 Nutra Food Ingredients Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Nutra Food Ingredients Bovine Bone Collagen Peptide Sales by Product in 2024
12.4.6 Nutra Food Ingredients Bovine Bone Collagen Peptide Sales by Application in 2024
12.4.7 Nutra Food Ingredients Bovine Bone Collagen Peptide Sales by Geographic Area in 2024
12.4.8 Nutra Food Ingredients Bovine Bone Collagen Peptide SWOT Analysis
12.4.9 Nutra Food Ingredients Recent Developments
12.5 Muyuankangtai
12.5.1 Muyuankangtai Corporation Information
12.5.2 Muyuankangtai Business Overview
12.5.3 Muyuankangtai Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.5.4 Muyuankangtai Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Muyuankangtai Bovine Bone Collagen Peptide Sales by Product in 2024
12.5.6 Muyuankangtai Bovine Bone Collagen Peptide Sales by Application in 2024
12.5.7 Muyuankangtai Bovine Bone Collagen Peptide Sales by Geographic Area in 2024
12.5.8 Muyuankangtai Bovine Bone Collagen Peptide SWOT Analysis
12.5.9 Muyuankangtai Recent Developments
12.6 Hebei Hongtao Bioengineering
12.6.1 Hebei Hongtao Bioengineering Corporation Information
12.6.2 Hebei Hongtao Bioengineering Business Overview
12.6.3 Hebei Hongtao Bioengineering Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.6.4 Hebei Hongtao Bioengineering Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Hebei Hongtao Bioengineering Recent Developments
12.7 Shandong Jellice Biotechnology
12.7.1 Shandong Jellice Biotechnology Corporation Information
12.7.2 Shandong Jellice Biotechnology Business Overview
12.7.3 Shandong Jellice Biotechnology Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.7.4 Shandong Jellice Biotechnology Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Shandong Jellice Biotechnology Recent Developments
12.8 Gelken Gelatin
12.8.1 Gelken Gelatin Corporation Information
12.8.2 Gelken Gelatin Business Overview
12.8.3 Gelken Gelatin Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.8.4 Gelken Gelatin Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Gelken Gelatin Recent Developments
12.9 Jianke Food Technology
12.9.1 Jianke Food Technology Corporation Information
12.9.2 Jianke Food Technology Business Overview
12.9.3 Jianke Food Technology Bovine Bone Collagen Peptide Product Models, Descriptions and Specifications
12.9.4 Jianke Food Technology Bovine Bone Collagen Peptide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Jianke Food Technology Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Bovine Bone Collagen Peptide Industry Chain
13.2 Bovine Bone Collagen Peptide Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Bovine Bone Collagen Peptide Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Bovine Bone Collagen Peptide Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Bovine Bone Collagen Peptide Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Bovine Bone Collagen Peptide Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Bovine Bone Collagen Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bovine Bone Collagen Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bovine Bone Collagen Peptide Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bovine Bone Collagen Peptide Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Bovine Bone Collagen Peptide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Bovine Bone Collagen Peptide Sales by Region (2020-2025) & (Tons)
 Table 8. Global Bovine Bone Collagen Peptide Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Bovine Bone Collagen Peptide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Bovine Bone Collagen Peptide Production by Region (2020-2025) & (Tons)
 Table 12. Global Bovine Bone Collagen Peptide Production by Region (2026-2031) & (Tons)
 Table 13. Global Bovine Bone Collagen Peptide Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Bovine Bone Collagen Peptide Sales Share by Manufacturers (2020-2025)
 Table 15. Global Bovine Bone Collagen Peptide Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Bovine Bone Collagen Peptide Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Bovine Bone Collagen Peptide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Bone Collagen Peptide as of 2024)
 Table 19. Global Bovine Bone Collagen Peptide Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Bovine Bone Collagen Peptide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Bovine Bone Collagen Peptide Manufacturing Base and Headquarters
 Table 22. Global Bovine Bone Collagen Peptide Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Bovine Bone Collagen Peptide Sales by Type (2020-2025) & (Tons)
 Table 26. Global Bovine Bone Collagen Peptide Sales by Type (2026-2031) & (Tons)
 Table 27. Global Bovine Bone Collagen Peptide Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Bovine Bone Collagen Peptide Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Bovine Bone Collagen Peptide ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Bovine Bone Collagen Peptide Sales by Application (2020-2025) & (Tons)
 Table 32. Global Bovine Bone Collagen Peptide Sales by Application (2026-2031) & (Tons)
 Table 33. Bovine Bone Collagen Peptide High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Bovine Bone Collagen Peptide Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Bovine Bone Collagen Peptide Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Bovine Bone Collagen Peptide ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Bovine Bone Collagen Peptide Growth Accelerators and Market Barriers
 Table 40. North America Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Bovine Bone Collagen Peptide Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Bovine Bone Collagen Peptide Growth Accelerators and Market Barriers
 Table 43. Europe Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Bovine Bone Collagen Peptide Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Bovine Bone Collagen Peptide Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Bovine Bone Collagen Peptide Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Bovine Bone Collagen Peptide Investment Opportunities and Key Challenges
 Table 50. Central and South America Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Bovine Bone Collagen Peptide Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Bovine Bone Collagen Peptide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. SEMNL Corporation Information
 Table 54. SEMNL Description and Major Businesses
 Table 55. SEMNL Product Models, Descriptions and Specifications
 Table 56. SEMNL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. SEMNL Sales Value Proportion by Product in 2024
 Table 58. SEMNL Sales Value Proportion by Application in 2024
 Table 59. SEMNL Sales Value Proportion by Geographic Area in 2024
 Table 60. SEMNL Bovine Bone Collagen Peptide SWOT Analysis
 Table 61. SEMNL Recent Developments
 Table 62. Honine Group Corporation Information
 Table 63. Honine Group Description and Major Businesses
 Table 64. Honine Group Product Models, Descriptions and Specifications
 Table 65. Honine Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Honine Group Sales Value Proportion by Product in 2024
 Table 67. Honine Group Sales Value Proportion by Application in 2024
 Table 68. Honine Group Sales Value Proportion by Geographic Area in 2024
 Table 69. Honine Group Bovine Bone Collagen Peptide SWOT Analysis
 Table 70. Honine Group Recent Developments
 Table 71. LONGBEI Corporation Information
 Table 72. LONGBEI Description and Major Businesses
 Table 73. LONGBEI Product Models, Descriptions and Specifications
 Table 74. LONGBEI Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. LONGBEI Sales Value Proportion by Product in 2024
 Table 76. LONGBEI Sales Value Proportion by Application in 2024
 Table 77. LONGBEI Sales Value Proportion by Geographic Area in 2024
 Table 78. LONGBEI Bovine Bone Collagen Peptide SWOT Analysis
 Table 79. LONGBEI Recent Developments
 Table 80. Nutra Food Ingredients Corporation Information
 Table 81. Nutra Food Ingredients Description and Major Businesses
 Table 82. Nutra Food Ingredients Product Models, Descriptions and Specifications
 Table 83. Nutra Food Ingredients Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Nutra Food Ingredients Sales Value Proportion by Product in 2024
 Table 85. Nutra Food Ingredients Sales Value Proportion by Application in 2024
 Table 86. Nutra Food Ingredients Sales Value Proportion by Geographic Area in 2024
 Table 87. Nutra Food Ingredients Bovine Bone Collagen Peptide SWOT Analysis
 Table 88. Nutra Food Ingredients Recent Developments
 Table 89. Muyuankangtai Corporation Information
 Table 90. Muyuankangtai Description and Major Businesses
 Table 91. Muyuankangtai Product Models, Descriptions and Specifications
 Table 92. Muyuankangtai Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Muyuankangtai Sales Value Proportion by Product in 2024
 Table 94. Muyuankangtai Sales Value Proportion by Application in 2024
 Table 95. Muyuankangtai Sales Value Proportion by Geographic Area in 2024
 Table 96. Muyuankangtai Bovine Bone Collagen Peptide SWOT Analysis
 Table 97. Muyuankangtai Recent Developments
 Table 98. Hebei Hongtao Bioengineering Corporation Information
 Table 99. Hebei Hongtao Bioengineering Description and Major Businesses
 Table 100. Hebei Hongtao Bioengineering Product Models, Descriptions and Specifications
 Table 101. Hebei Hongtao Bioengineering Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Hebei Hongtao Bioengineering Recent Developments
 Table 103. Shandong Jellice Biotechnology Corporation Information
 Table 104. Shandong Jellice Biotechnology Description and Major Businesses
 Table 105. Shandong Jellice Biotechnology Product Models, Descriptions and Specifications
 Table 106. Shandong Jellice Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Shandong Jellice Biotechnology Recent Developments
 Table 108. Gelken Gelatin Corporation Information
 Table 109. Gelken Gelatin Description and Major Businesses
 Table 110. Gelken Gelatin Product Models, Descriptions and Specifications
 Table 111. Gelken Gelatin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Gelken Gelatin Recent Developments
 Table 113. Jianke Food Technology Corporation Information
 Table 114. Jianke Food Technology Description and Major Businesses
 Table 115. Jianke Food Technology Product Models, Descriptions and Specifications
 Table 116. Jianke Food Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Jianke Food Technology Recent Developments
 Table 118. Key Raw Materials Distribution
 Table 119. Raw Materials Key Suppliers
 Table 120. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 121. Milestones in Production Technology Evolution
 Table 122. Distributors List
 Table 123. Market Trends and Market Evolution
 Table 124. Market Drivers and Opportunities
 Table 125. Market Challenges, Risks, and Restraints
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bovine Bone Collagen Peptide Product Picture
 Figure 2. Global Bovine Bone Collagen Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Protein<90% Product Picture
 Figure 4. Protein≥90% Product Picture
 Figure 5. Global Bovine Bone Collagen Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Food
 Figure 7. Cosmetics
 Figure 8. Pharmaceutical
 Figure 9. Bovine Bone Collagen Peptide Report Years Considered
 Figure 10. Global Bovine Bone Collagen Peptide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Bovine Bone Collagen Peptide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Bovine Bone Collagen Peptide Revenue Market Share by Region (2020-2031)
 Figure 14. Global Bovine Bone Collagen Peptide Sales (2020-2031) & (Tons)
 Figure 15. Global Bovine Bone Collagen Peptide Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Bovine Bone Collagen Peptide Sales Market Share by Region (2020-2031)
 Figure 17. Global Bovine Bone Collagen Peptide Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Bovine Bone Collagen Peptide Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Bovine Bone Collagen Peptide Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Bovine Bone Collagen Peptide Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Bovine Bone Collagen Peptide Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Bovine Bone Collagen Peptide Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Bovine Bone Collagen Peptide Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Bovine Bone Collagen Peptide Sales Volume Market Share in 2024
 Figure 26. Global Bovine Bone Collagen Peptide Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Protein<90% Revenue Market Share by Manufacturer in 2024
 Figure 29. Protein≥90% Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Bovine Bone Collagen Peptide Sales Market Share by Type (2020-2031)
 Figure 33. Global Bovine Bone Collagen Peptide Revenue Market Share by Type (2020-2031)
 Figure 34. Global Bovine Bone Collagen Peptide Sales Market Share by Application (2020-2031)
 Figure 35. Global Bovine Bone Collagen Peptide Revenue Market Share by Application (2020-2031)
 Figure 36. North America Bovine Bone Collagen Peptide Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Bovine Bone Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Bovine Bone Collagen Peptide Sales Revenue (US$ Million) in 2024
 Figure 39. North America Bovine Bone Collagen Peptide Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Bovine Bone Collagen Peptide Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Bovine Bone Collagen Peptide Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Bovine Bone Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Bovine Bone Collagen Peptide Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Bovine Bone Collagen Peptide Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Bovine Bone Collagen Peptide Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 54. France Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Bovine Bone Collagen Peptide Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Bovine Bone Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Bovine Bone Collagen Peptide Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Bovine Bone Collagen Peptide Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Bovine Bone Collagen Peptide Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 69. India Bovine Bone Collagen Peptide Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Bovine Bone Collagen Peptide Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Bovine Bone Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Bovine Bone Collagen Peptide Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Bovine Bone Collagen Peptide Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Bovine Bone Collagen Peptide Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Bovine Bone Collagen Peptide Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Bovine Bone Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Bovine Bone Collagen Peptide Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Bovine Bone Collagen Peptide Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Bovine Bone Collagen Peptide Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Bovine Bone Collagen Peptide Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Bovine Bone Collagen Peptide Revenue (2020-2025) & (US$ Million)
 Figure 90. Bovine Bone Collagen Peptide Industry Chain Mapping
 Figure 91. Regional Bovine Bone Collagen Peptide Manufacturing Base Distribution (%)
 Figure 92. Bovine Bone Collagen Peptide Production Process
 Figure 93. Regional Bovine Bone Collagen Peptide Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart